Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
PNNL researchers Lisa Bramer and Sarah Reehl were on a team that received a patent for its work with electron microscopy. Electron microscopy allows scientists to make nanoscale observations of materials.
The National Association of Mathematics named PNNL Data Analyst Brett Jefferson best speaker for his presentation on an innovative mathematical finding that could be used to improve electric grid coverage.
A new study focusing on the proteins involved in endometrial cancer, commonly known as uterine cancer, offers insights about which patients will need aggressive treatment and which won’t.
A new book by PNNL biochemist Erick Merkley details forensic proteomics, a technique that directly analyzes proteins in unknown samples, in pursuit of making proteomics a widespread forensic method when DNA is missing or ambiguous.
At a conference featuring the most advanced computing hardware and software, ML in its various guises was on full display and highlighted by Nathan Baker’s featured invited presentation.
PNNL scientists Richard (Dick) Smith and Ljiljana (Lili) Paša-Tolić are recognized by The Analytical Scientist in its 2019 Power List as two of 2019’s top 100 minds in analytical science.
Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
